Eveia Medical Revenue and Competitors

Eveia Medical has developed a series of proprietary testing platforms that will enable healthcare providers and life science researchers to better manage patients, diagnose disease and develop targeted therapeutics and diagnostics. Eveia’s HIA (Homogeneous ImmunoAssay) system is a technology that is capable of sensitive, rapid and reliable measurements of virtually any biomarker for clinical laboratories, physician office laboratories and research laboratories with enhanced specificity. Eveia’s Rapid Testing (Point-of-Care) technology enables cost effective management of many of the most common disease states, and completely eliminates the need for any instrumentation or reagents. Systems include tests for anemia (Hb), coagulation (Coumadin therapy), therapeutic drug management and numerous other applications in clinical medicine.